AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Hannover Rueck SE

Quarterly Report May 6, 2021

197_10-q_2021-05-06_41c6da20-8d18-40df-8b57-b535197de634.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

Quarterly Statement as at 31 March 2021

Key figures

EUR million 2021 2020
1.1. – 31.3. +/ – previous
year
1.1. – 31.3. 31.12.
Results
Gross written premium 7,803.2 +11.9% 6,975.3
Net premium earned 5,686.6 +11.7% 5,090.9
Net underwriting result 1 22.5 (44.8)
Net investment income 444.0 -5.9% 471.7
Operating profit (EBIT) 403.8 -5.3% 426.6
Group net income 305.9 +1.7% 300.9
Balance sheet
Policyholders' surplus 14,822.2 +5.3% 14,071.0
Equity attributable to shareholders of Hannover Rück SE 11,043.0 +0.4% 10,995.0
Non-controlling interests 803.3 -4.9% 844.4
Hybrid capital 2,976.0 +33.4% 2,231.6
Investments (excl. funds withheld by ceding companies) 52,511.1 +6.7% 49,220.9
Total assets 77,044.4 +7.8% 71,439.8
Share
Earnings per share (basic and diluted) in EUR 2.54 +1.7% 2.49
Book value per share in EUR 91.57 +0.4% 86.77 91.17
Share price at the end of the period in EUR 155.80 +19.6% 131.00 130.30
Market capitalisation at the end of the period 18,789.0 +19.6% 15,798.2 15,713.8
Ratios
Combined ratio (property and casualty reinsurance) 1 96.2% 99.8%
Large losses as percentage of net premium earned
(property and casualty reinsurance) 2
5.0% 8.5%
Retention 91.5% 91.1%
Return on investment (excl. funds withheld by ceding companies) 2.5% 3.2%
EBIT margin3 7.1% 8.4%
Return on equity (after tax) 11.1% 11.5%

1 Including funds withheld

2 Hannover Re Group's net share for natural catastrophes and other major losses in excess of EUR 10 million gross as a percentage of net premium earned

3 Operating result (EBIT)/net premium earned

Contents

Quarterly Statement 2
Business development 2
Results of operations, financial position and net assets 4
Property and casualty reinsurance 4
Life and health reinsurance 5
Investments 6
Outlook 9
Consolidated balance sheet as at 31 March 2021 10
Consolidated statement of income as at 31 March 2021 12
Consolidated statement of comprehensive income as at 31 March 2021 13
Consolidated segment report as at 31 March 2021 14
Consolidated cash flow statement as at 31 March 2021 18
Other information 19
Contact information 20

The present document is a quarterly statement pursuant to Section 51a of the Exchange Rules for the Frankfurter Wertpapierbörse. For further information please see the section "Other information" on page 19 of this document.

Quarterly Statement as at 31 March 2021

Business development

  • Group gross premium grows by 16.8% in the first quarter adjusted for exchange rate effects
  • Pandemic-related strains of EUR 151 million in life and health reinsurance
  • Return on investment reaches 2.5%
  • Group net income rises by 1.7% to EUR 305.9 million
  • Return on equity beats minimum target at 11.1%

The first quarter of 2021 passed off in line with Hannover Re's expectations and was again notable for vigorous growth, especially in property and casualty reinsurance. Social and economic developments around the world continue to be dominated by the Covid-19 pandemic. As vaccinations rise and tests become more widely available, the losses caused by the pandemic should trend appreciably lower going forward.

Gross written premium for the Group rose by 11.9% to EUR 7.8 billion (previous year: EUR 7.0 billion) as at the end of March. Growth would have reached 16.8% at constant exchange rates. The retention increased to 91.5% (91.1%). Net premium earned grew by 11.7% to EUR 5.7 billion (EUR 5.1 billion). The increase would have been 16.4% adjusted for exchange rate effects.

In our Property & Casualty reinsurance business group the treaty renewals as at 1 January 2021 proved highly satisfactory on the whole. The positive pricing momentum of the past year was sustained here. What is more, we had already additionally boosted our IBNR reserves for Covid-19-related losses at the end of the 2020 financial year, thereby significantly reducing the risk of having to set aside further reserves in property and casualty reinsurance. In the course of the first quarter, therefore, no additional net strains were incurred in relation to Covid-19. The segment result consequently improved by 29.9%.

In Life & Health reinsurance, on the other hand, additional loss expenditures were recorded in connection with the elevated mortality resulting from the pandemic – most notably in the United States. These should, however, already begin to recede appreciably in the second quarter as the pace of vaccinations picks up. The additional strains incurred from the pandemic in the first quarter totalled EUR 151 million. This contrasted with positive one-time income of EUR 129.3 million from a restructuring measure in US mortality business. All in all, the first three months of the year passed off satisfactorily – thanks also to pleasing demand for financial solutions. The segment result deteriorated by 55.7% on account of pandemic-related losses.

Our portfolio of investments amounted to EUR 52.5 billion, corresponding to an increase of 6.7% compared to the position as at 31 December 2020. Investment income contracted as anticipated by 5.9% year-on-year and an annualised average return of 2.5% was generated.

Other income and expenses declined by 20.5% to EUR 67.9 million (EUR 85.4 million). This was driven primarily by movements in exchange rates, which particularly impacted the result in property and casualty reinsurance.

The operating profit (EBIT) generated by Hannover Re on the Group level fell by 5.3% to EUR 403.8 million (EUR 426.6 million). Group net income improved by a modest 1.7% to EUR 305.9 million (EUR 300.9 million) on the back of lower tax expenditure. Earnings per share thus came in at EUR 2.54 (EUR 2.49).

In March Hannover Rück SE issued subordinated debt in a nominal amount of EUR 750 million. The bond has a maturity date of 30 June 2042 and a first scheduled call option on 30 December 2031. In an attractive market environment it enables us, among other things, to act on additional market opportunities that emerge from the current favourable pricing trend on global reinsurance markets.

The shareholders' equity of Hannover Re as at 31 March 2021 climbed by 0.4% to EUR 11.0 billion (31 December 2020: EUR 11.0 billion). The annualised return on equity amounted to 11.1% (31 December 2020: 8.2%) and hence beat our minimum target of 900 basis points above the risk-free interest rate. The book value per share stood at EUR 91.57 (31 December 2020: EUR 91.17). The capital adequacy ratio at the end of March was 252%, a level comfortably in excess of our internal limit of 180% and our threshold of 200%.

Going forward, the issue of sustainability will exert an even greater influence on the selection and composition of our investments and on our business. We recently took additional steps by signing the United Nations-supported Principles for Responsible Investment and the UN-backed Principles for Sustainable Insurance. Both in our underwriting activities and on the investment side we shall promote the expansion of environmentally-friendly technologies and progressively scale back our exposure to technologies that are harmful to the climate. This has been enshrined accordingly in our sustainability strategy, under which we have additionally set ourselves the goal of stepping up our commitment to closing the protection gap in developing countries and thereby enabling more people to access adequate insurance coverage.

Results of operations, financial position and net assets

Property and casualty reinsurance

  • Gross premium in property and casualty reinsurance up by 20.1% adjusted for exchange rate effects
  • No further pandemic-related losses for net account in the first quarter
  • Combined ratio improves significantly to 96.2%
  • Thoroughly satisfactory 1 January renewals; sustained improvements in prices and conditions
  • Segment result climbs by 29.9% year-on-year

In property and casualty reinsurance no additional net strains were incurred in the first quarter for Covid-19-related losses. We continue to assume that we had largely reserved the losses anticipated from the Covid-19 pandemic back in the 2020 financial year.

Against the backdrop of the continued tense risk situation around the world, the main renewal season in traditional property and casualty reinsurance as at 1 January 2021 passed off thoroughly satisfactorily overall for Hannover Re. The pricing momentum of the past year was sustained and we again generated pleasing growth in our renewed portfolio at improved prices and conditions. Some 67% of Hannover Re's traditional property and casualty reinsurance portfolio (excluding facultative reinsurance, ILS activities and structured reinsurance) was up for renewal on 1 January. The average price increase amounted to 5.5%, reflecting further improvements in prices and conditions that varied in scope across all lines and regions.

Gross written premium in property and casualty reinsurance surged by a substantial 14.2% in the first quarter to EUR 5.7 billion (previous year: EUR 5.0 billion). Growth would have reached 20.1% at constant exchange rates. Net premium earned rose by 15.7% to EUR 3.9 billion (EUR 3.3 billion); at constant exchange rates, growth of 21.5% would have been recorded.

The burden of large losses came to altogether EUR 193.2 million (EUR 283.6 million), a figure slightly below our major loss budget for the first quarter of EUR 214 million. No additional net strains were incurred in relation to Covid-19. The largest individual losses were the outbreak of extreme winter weather in the US state of Texas, with net expenditure of EUR 75.4 million, an industrial loss in Germany costing EUR 34.8 million and flood damage in Australia amounting to EUR 19.5 million. The combined ratio in property and casualty reinsurance improved significantly to 96.2% (99.8%) and was thus marginally higher than our anticipated maximum level of 96%.

The underwriting result for total property and casualty reinsurance including interest on funds withheld and contract deposits similarly improved considerably to EUR 147.3 million (EUR 7.2 million). The investment income booked from assets under own management declined, on the other hand, by 6.3% to EUR 267.9 million (EUR 286.1 million). Exchange losses of EUR 82.2 million, which were opposed by positive exchange rate movements in equity, were a corresponding drag on the segment result.

The operating profit (EBIT) climbed by 6.3% to EUR 324.0 million (EUR 304.7 million). The EBIT margin reached 8.4% (9.1%). The net income generated by the Property & Casualty reinsurance business group increased by 29.9% to EUR 269.2 million (EUR 207.3 million).

Key figures for property and casualty reinsurance

in EUR million 2021 2020
1.1. – 31.3. +/ – previous year 1.1. – 31.3.
Gross written premium 5,692.9 +14.2% 4,986.1
Net premium earned 3,863.1 +15.7% 3,338.0
Underwriting result 1 147.3 7.2
Net investment income 271.5 -8.4% 296.4
Operating result (EBIT) 324.0 +6.3% 304.7
Group net income 269.2 +29.9% 207.3
Earnings per share in EUR 2.23 +29.9% 1.72
EBIT margin2 8.4% 9.1%
Combined ratio 1 96.2% 99.8%
Retention 92.6% 91.7%

1 Including funds withheld

2 Operating result (EBIT)/net premium earned

Life and health reinsurance

  • Gross premium for the Life & Health reinsurance business group up by 8.6% adjusted for exchange rate effects
  • Strains of EUR 151 million from the Covid-19 pandemic in the first quarter
  • Sustained strong demand worldwide for covers in the area of financial solutions
  • Segment result well below the previous year at EUR 48.8 million

The impacts of the pandemic continued to be the dominant issue in life and health reinsurance, particularly in the area of mortality covers. The strains relating to Covid-19 amounted to EUR 151 million in the first quarter. While further loss expenditures are to be expected in life and health reinsurance, it is nevertheless our assumption that the losses in the second quarter will already be appreciably lower and will continue to trend downwards as the year progresses.

As already reported in connection with the 2020 annual financial statement, the additional strains anticipated from the pandemic are opposed by positive one-time income from a restructuring measure in US mortality business amounting to EUR 129.3 million. At the same time, we are benefiting from sustained strong demand worldwide in our financial solutions business. While the focus of new business here remains on the United States and Asia, the lively interest shown among customers is now generating new business opportunities in other markets too. Solutions designed to cover longevity risks similarly attracted growing attention worldwide in the first quarter. While demand was again especially strong in the United Kingdom, insurers and pension funds in Germany also took a keen interest in covers for the longevity risk. The landscape for life and health reinsurance was satisfactory on the whole in the first quarter.

Gross premium income in the Life & Health reinsurance business group climbed by 6.1% to EUR 2.1 billion (previous year: EUR 2.0 billion); growth of 8.6% would have been booked at constant exchange rates. Net premium earned grew by 4.0% to EUR 1.8 billion (EUR 1.8 billion); the increase would have been 6.7% adjusted for exchange rate effects.

Investment income from assets under own management fell by 54.7% to EUR 45.0 million (EUR 99.4 million), inter alia in connection with the performance of a derivative. The operating result (EBIT) declined by 35.6% to EUR 80.1 million (EUR 124.2 million). Net income for the Life & Health reinsurance business group contracted sharply by 55.7% to EUR 48.8 million (EUR 110.2 million) on account of the considerable Covid-19-related losses.

Key figures for life and health reinsurance

in EUR million 2021 2020
1.1. – 31.3. +/ – previous year 1.1. – 31.3.
Gross written premium 2,110.3 +6.1% 1,989.2
Net premium earned 1,823.6 +4.0% 1,752.8
Investment income 172.0 -1.5% 174.7
Operating result (EBIT) 80.1 -35.6% 124.2
Net income after tax 48.8 -55.7% 110.2
Earnings per share in EUR 0.40 -55.7% 0.91
Retention 88.6% 89.4%
EBIT margin1 4.4% 7.1%

1 Operating result (EBIT)/net premium earned

Investments

  • Interest rate level still very low even after rising in the first quarter
  • Portfolio of assets under own management grows to EUR 52.5 billion
  • Investment income falls as expected by 5.9% to EUR 444.0 million
  • Return on investment reaches 2.5%

Our investments delivered a very pleasing performance in the first three months of the year. On the key fixed-income markets for our company increases in the interest rate level – which in some instances were very appreciable – were observed in our main currency areas, especially in the longer maturity segments; these were beneficial both for new investments and reinvestment activities. On the whole, though, interest rates remained on a very low level. Euro bond yields, for example, were negative beyond the ten-year mark. Reductions in risk premiums have been seen on emerging market bonds and for lower-quality issuers since the beginning of the year. Equity markets trended sharply higher in the first quarter, thanks in part to the continued supportive approach taken by central banks.

Our portfolio of assets under own management increased to EUR 52.5 billion (31 December 2020: EUR 49.2 billion). With credit spreads virtually unchanged, higher interest rates led to declines in the fair values of our fixed-income securities. These were comfortably offset by positive currency effects, primarily from the US dollar and pound sterling. The inflow of cash from issuance of a bond and the one-time reclassification of holdings from the technical account to investments as part of a restructuring measure in US mortality business also had favourable implications for the portfolio. The unrealised gains in our fixed-income portfolio contracted above all due to rising interest rates to EUR 1.5 billion (31 December 2020: EUR 2.6 billion) as at the end of March.

In the first quarter we increasingly focused our new investments and reinvestment activities in the area of fixed-income securities on instruments that offer higher returns – in due consideration of the risk profiles – relative to government bonds. The modified duration of our fixed-income portfolio – at 5.7 (5.8) – was reduced marginally in comparison with the end of the previous year. We also made the most of market opportunities and disposed of parts of our equity holdings.

Ordinary investment income excluding interest on funds withheld and contract deposits amounted to EUR 313.2 million, a level slightly below the previous year's period (EUR 326.3 million). Earnings from fixed-income securities were down significantly. This can also be attributed in part to lower inflation, which gives rise to reduced amortisation amounts in our portfolio of inflation-linked bonds. Investments in the real estate sector delivered somewhat lower earnings, while alternative investments proved substantially more profitable than in the comparable period. Interest on funds withheld and contract deposits climbed very sharply to EUR 130.5 million (EUR 85.6 million).

The net balance of gains realised on disposals totalled EUR 90.2 million (EUR 101.9 million) and can be attributed primarily to regrouping moves as part of regular portfolio maintenance as well as the aforementioned share sales. Impairments of altogether EUR 21.1 million (EUR 28.6 million) were taken. Of this amount, write-downs of EUR 8.0 million (EUR 5.6 million) were attributable to alternative investments, together with impairments of EUR 4.0 million (EUR 3.0 million) on real estate funds. The depreciation recognised on directly held real estate came to EUR 8.9 million (EUR 9.2 million).

We recognise a derivative for the credit risk associated with special life reinsurance treaties (ModCo) under which securities deposits are held by cedants for our account; the performance of this derivative gave rise to unrealised losses of EUR 14.4 million (loss of EUR 26.6 million) recognised in investment income. In economic terms we assume a neutral development for this item. Altogether, the unrealised losses in our assets recognised at fair value through profit or loss amounted to EUR 49.7 million (gain of EUR 11.6 million) in the first quarter, crucially influenced by the performance of another derivative relating to a life reinsurance treaty.

The net investment income of EUR 444.0 million (EUR 471.7 million) was lower than in the comparable period. Income from assets under own management accounted for EUR 313.5 million (EUR 386.1 million), producing an annualised average return (including ModCo effects) of 2.5%.

Going forward, sustainability considerations will exert an even greater influence on the selection and composition of our investments. We continuously apply our sustainability strategy in our investing activities and regularly review our portfolio to verify conformity with our policy on coal and the ESG criteria that we have set ourselves. What is more, we are increasingly investing in sustainable infrastructure investments and impact investment funds, the goal of which is to generate not only a positive financial return but also measurably positive effects on the environment and society. In accordance with the Paris Agreement on climate change we are actively reducing the carbon intensity of our investments. We signed the UN-supported Principles for Responsible Investment (PRI) last year with a view to underscoring our stepped-up commitment to sustainability.

Net investment income

in EUR million 2021 2020
1.1. – 31.3. +/ – previous year 1.1. – 31.3.
Ordinary investment income 1 313.2 -4.0% 326.3
Result from participations in associated companies 12.2 +90.0% 6.4
Realised gains /losses 90.2 -11.5% 101.9
Appreciation2 21.1 -26.3% 28.6
Change in fair value of financial instruments 3 (49.7) 11.6
Investment expenses 31.3 -0.7% 31.6
Net investment income from assets under own management 313.5 -18.8% 386.1
Net investment income from funds withheld 130.5 +52.5% 85.6
Total investment income 444.0 -5.9% 471.7

1 Excluding expenses on funds withheld and contract deposits

2 Including depreciation/impairments on real estate

3 Portfolio at fair value through profit or loss and trading

Rating structure of our fixed-income securities 1

Rating classes Government bonds Securities issued
by semi-governmental
entities 2
Corporate bonds Covered bonds /asset
backed securities
in % in EUR
million
in % in EUR
million
in % in EUR
million
in % in EUR
million
AAA 74.6 12,877.5 59.7 4,536.4 0.6 94.6 59.1 1,878.5
AA 8.4 1,456.9 23.7 1,805.4 11.5 1,883.3 17.4 553.8
A 10.9 1,890.3 7.4 559.0 32.7 5,342.1 13.4 427.9
BBB 4.2 729.8 1.6 124.7 44.7 7,279.2 8.3 263.5
< BBB 1.9 329.0 7.6 579.2 10.5 1,718.7 1.8 58.5
Total 100.0 17,283.6 100.0 7,604.7 100.0 16,318.0 100.0 3,182.2

1 Securities held through investment funds are recognised pro rata with their corresponding individual ratings.

2 Including government-guaranteed corporate bonds

Outlook

  • Group gross premium expected to show growth in the upper single-digit percentages for 2021 at constant exchange rates
  • Return on investment of roughly 2.4% anticipated for the full year
  • Group net income guidance of EUR 1.15 billion to EUR 1.25 billion for 2021 confirmed

The Covid-19 pandemic continues to set the tone for global reinsurance markets in the 2021 financial year. Particularly in life and health reinsurance, further losses will be dependent on the success of ongoing vaccination campaigns and additional containment efforts. It is our assumption that the pandemic-related strains will already start to recede appreciably from the second quarter onwards. We therefore consider ourselves well placed overall to achieve our guidance for the current financial year.

On the Group level our expected net income for the 2021 financial year remains unchanged at EUR 1.15 billion to EUR 1.25 billion, with the return on investment anticipated to be roughly 2.4% and Group gross premium forecast to show growth in the upper single-digit percentages adjusted for exchange rate effects. In addition, we have raised our net major loss budget to EUR 1.1 billion (EUR 975 million). The increase in the budget was prompted above all by the continued growth in the underlying business.

We renew our business in Japan and to a lesser extent in Australia, New Zealand, Asian markets and North America as at 1 April. Building on the 1 January 2021 renewals, these negotiations also concluded favourably for Hannover Re. The premium volume booked from this round of treaty renewals rose by altogether 7.4%. The price increase for the renewed business amounted to 5.0%.

Our dividend policy remains unchanged. Hannover Re envisages a payout ratio for the ordinary dividend in the range of 35% to 45% of IFRS Group net income. The ordinary dividend will be supplemented by payment of a special dividend subject to a comfortable level of capitalisation and Group net income within the bounds of expectations.

Consolidated balance sheet as at 31 March 2021

Assets
in EUR thousand 31.3.2021 31.12.2020
Fixed-income securities – held to maturity 150,075 185,577
Fixed-income securities – loans and receivables 2,689,612 2,532,146
Fixed-income securities – available for sale 41,433,632 38,851,723
Fixed-income securities – at fair value through profit or loss 115,080 105,711
Equity securities – available for sale 281,022 378,422
Other financial assets – at fair value through profit or loss 181,209 234,689
Investment property 1,631,097 1,589,238
Real estate funds 633,255 582,296
Investments in associated companies 376,553 361,617
Other invested assets 2,974,693 2,794,016
Short-term investments 630,478 327,426
Cash and cash equivalents 1,414,365 1,278,071
Total investments and cash under own management 52,511,071 49,220,932
Funds withheld 10,273,226 9,659,807
Contract deposits 328,678 298,344
Total investments 63,112,975 59,179,083
Reinsurance recoverables on unpaid claims 1,886,184 1,883,270
Reinsurance recoverables on benefit reserve 203,080 192,135
Prepaid reinsurance premium 227,850 165,916
Reinsurance recoverables on other technical reserves 1,293 1,106
Deferred acquisition costs 3,282,738 2,857,071
Accounts receivable 6,798,902 5,605,803
Goodwill 83,557 80,965
Deferred tax assets 599,885 597,986
Other assets 828,338 858,170
Accrued interest and rent 19,556 18,264
Total assets 77,044,358 71,439,769

Liabilities

in EUR thousand 31.3.2021 31.12.2020
Loss and loss adjustment expense reserve 36,018,320 33,929,230
Benefit reserve 7,516,753 7,217,988
Unearned premium reserve 6,798,468 5,070,009
Other technical provisions 763,068 701,577
Funds withheld 635,841 582,316
Contract deposits 3,524,425 3,255,453
Reinsurance payable 1,824,397 1,777,761
Provisions for pensions 213,929 229,252
Taxes 161,259 132,736
Deferred tax liabilities 2,615,952 2,731,648
Other liabilities 943,543 541,107
Long-term debt and notes payable 4,182,154 3,431,276
Total liabilities 65,198,109 59,600,353
Shareholders' equity
Common shares 120,597 120,597
Nominal value: 120.597
Conditional capital: 60.299
Additional paid-in capital 724,562 724,562
Common shares and additional paid-in capital 845,159 845,159
Cumulative other comprehensive income
Unrealised gains and losses on investments 1,595,207 2,275,936
Cumulative foreign currency translation adjustment 80,700 (330,693)
Changes from hedging instruments (7,380) (8,678)
Other changes in cumulative other comprehensive income (74,234) (83,792)
Total other comprehensive income 1,594,293 1,852,773
Retained earnings 8,603,514 8,297,114
Equity attributable to shareholders of Hannover Rück SE 11,042,966 10,995,046
Non-controlling interests 803,283 844,370
Total shareholders' equity 11,846,249 11,839,416
Total liabilities and shareholders' equity 77,044,358 71,439,769

Consolidated statement of income as at 31 March 2021

in EUR thousand 1.1.–31.3.2021 1.1.–31.3.2020
Gross written premium 7,803,194 6,975,289
Ceded written premium 663,044 623,686
Change in gross unearned premium (1,507,345) (1,338,110)
Change in ceded unearned premium 53,832 77,366
Net premium earned 5,686,637 5,090,859
Ordinary investment income 313,164 326,260
Profit/loss from investments in associated companies 12,212 6,426
Realised gains and losses on investments 90,182 101,864
Change in fair value of financial instruments (49,699) 11,644
Total depreciation, impairments and appreciation of investments 21,054 28,569
Other investment expenses 31,324 31,554
Net income from investments under own management 313,481 386,071
Income/expense on funds withheld and contract deposits 130,501 85,587
Net investment income 443,982 471,658
Other technical income 62
Total revenues 6,130,681 5,562,517
Claims and claims expenses 4,385,771 3,924,954
Change in benefit reserves (52,287) (84,789)
Commission and brokerage, change in deferred acquisition costs 1,334,036 1,265,512
Other acquisition costs 1,089 1,103
Administrative expenses 126,109 114,494
Total technical expenses 5,794,718 5,221,274
Other income 261,531 289,333
Other expenses 193,660 203,931
Other income and expenses 67,871 85,402
Operating profit/loss (EBIT) 403,834 426,645
Financing costs 18,720 23,461
Net income before taxes 385,114 403,184
Taxes 65,849 94,152
Net income 319,265 309,032
thereof
Non-controlling interest in profit and loss 13,372 8,155
Group net income 305,893 300,877
Earnings per share (in EUR)
Basic earnings per share 2.54 2.49
Diluted earnings per share 2.54 2.49

Consolidated statement of comprehensive income as at 31 March 2021

in EUR thousand 1.1.–31.3.2021 1.1. –31.3.2020
Net income 319,265 309,032
Not reclassifiable to the consolidated statement of income
Actuarial gains and losses
Gains (losses) recognised directly in equity 14,563 23,950
Tax income (expense) (4,759) (7,790)
9,804 16,160
Changes from the measurement of associated companies
Gains (losses) recognised directly in equity 134 98
134 98
Income and expense recognised directly in equity that cannot be reclassified
Gains (losses) recognised directly in equity 14,697 24,048
Tax income (expense) (4,759) (7,790)
9,938 16,258
Reclassifiable to the consolidated statement of income
Unrealised gains and losses on investments
Gains (losses) recognised directly in equity (851,093) (542,933)
Transferred to the consolidated statement of income (82,191) (67,308)
Tax income (expense) 233,449 200,683
(699,835) (409,558)
Currency translation
Gains (losses) recognised directly in equity 475,221 (7,961)
Tax income (expense) (58,012) 13,255
417,209 5,294
Changes from the measurement of associated companies
Gains (losses) recognised directly in equity 2,507 (3,751)
2,507 (3,751)
Changes from hedging instruments
Gains (losses) recognised directly in equity 2,264 (7,312)
Tax income (expense) (945) 3,667
1,319 (3,645)
Reclassifiable income and expense recognised directly in equity
Gains (losses) recognised directly in equity (371,101) (561,957)
Transferred to the consolidated statement of income (82,191) (67,308)
Tax income (expense) 174,492 217,605
(278,800) (411,660)
Total income and expense recognised directly in equity
Gains (losses) recognised directly in equity (356,404) (537,909)
Transferred to the consolidated statement of income (82,191) (67,308)
Tax income (expense) 169,733 209,815
(268,862) (395,402)
Total recognised income and expense 50,403 (86,370)
thereof
Attributable to non-controlling interests 2,990 (22,870)
Attributable to shareholders of Hannover Rück SE 47,413 (63,500)

Group segment report as at 31 March 2021

Segmentation of liabilities

in EUR thousand
Liabilities
Loss and loss adjustment expense reserve 30,770,748 29,194,354
Benefit reserve
Unearned premium reserve 6,377,393 4,709,229
Provisions for contingent commissions 451,307 395,296
Funds withheld 384,563 342,420
Contract deposits 80,464 80,369
Reinsurance payable 1,222,473 1,157,650
Long-term liabilities 426,637 420,348
Other liabilities in the segment 2,714,986 2,483,144
Total liabilities 42,428,571 38,782,810
Property and casualty reinsurance Life and health reinsurance
Consolidation
Total
31.3.2021
31.12.2020
31.3.2021 31.12.2020 31.3.2021 31.12.2020 31.3.2021 31.12.2020
139,867 28,376 45,710 150,075 185,577
2,217,917 327,652 299,180 15,271 15,049 2,689,612 2,532,146
29,422,685 10,080,256 9,429,038 1,687 41,433,632 38,851,723
378,422 281,022 378,422
110,304 177,907 230,096 296,289 340,400
4,384,139 962,207 920,960 3,601 22,068 5,615,598 5,327,167
244,474 173,033 82,221 1,168 731 630,478 327,426
901,989 331,280 371,972 28,936 4,110 1,414,365 1,278,071
37,799,797 12,080,711 11,379,177 50,663 41,958 52,511,071 49,220,932
2,569,420 7,100,041 7,090,387 10,273,226 9,659,807
5,404 325,544 292,940 328,678 298,344
40,374,621 19,506,296 18,762,504 50,663 41,958 63,112,975 59,179,083
1,730,507 151,940 152,763 1,886,184 1,883,270
203,080 192,135 203,080 192,135
165,834 81 82 227,850 165,916
562 730 544 1,293 1,106
1,169,521 1,740,003 1,687,550 3,282,738 2,857,071
4,155,372 1,623,089 1,450,628 (192) (197) 6,798,902 5,605,803
2,579,470 474,612 469,316 (1,538,325) (1,493,401) 1,531,336 1,555,385
50,175,887 23,699,831 22,715,522 (1,487,854) (1,451,640) 77,044,358 71,439,769
33,929,230 36,018,320 4,734,876 5,247,572
7,217,988 7,516,753 7,217,988 7,516,753
5,070,009 6,798,468 360,780 421,075
701,577 763,068 306,281 311,761
582,316 635,841 239,896 251,278
3,255,453 3,524,425 3,175,084 3,443,961
1,777,761 1,824,397 620,111 601,924
3,431,276 4,182,154 2,975,918 3,720,467 35,010 35,050
3,634,743 3,934,683 (1,500,873) (1,495,823) 2,652,472 2,715,520
59,600,353 65,198,109 1,475,045 2,224,644 19,342,498 20,544,894
Segment statement of income Property and casualty reinsurance
in EUR thousand 1.1.–31.3.2021 1.1.–31.3.2020
Gross written premium 5,692,888 4,986,069
Net premium earned 3,863,057 3,338,019
Net investment income 271,469 296,425
thereof
Change in fair value of financial instruments 1,720 (2,193)
Total depreciation, impairments and appreciation of investments 21,046 27,050
Income/expense on funds withheld and contract deposits 3,543 10,355
Claims and claims expenses 2,642,608 2,341,524
Change in benefit reserve
Commission and brokerage, change in deferred acquisition costs and other technical
income/expenses
1,015,608 945,733
Administrative expenses 61,053 53,946
Other income and expenses (91,268) 11,477
Operating profit/loss (EBIT) 323,989 304,718
Financing costs 522 543
Net income before taxes 323,467 304,175
Taxes 41,605 89,317
Net income 281,862 214,858
thereof
Non-controlling interest in profit or loss 12,694 7,577
Group net income 269,168 207,281
Consolidation
Total
Life and health reinsurance
1.1.– 31.3.2020 1.1.–31.3.2021 1.1.–31.3.2020 1.1.–31.3.2021 1.1. –31.3.2020 1.1. –31.3.2021
6,975,289 7,803,194 1,989,220 2,110,306
5,090,859 5,686,637 59 1,752,781 1,823,580
471,658 443,982 577 535 174,656 171,978
11,644 (49,699) 13,837 (51,419)
28,569 21,054 1,519 8
85,587 130,501 75,232 126,958
3,924,954 4,385,771 1,583,430 1,743,163
(84,789) (52,287) (84,789) (52,287)
1,266,615 1,335,063 320,882 319,455
114,494 126,109 134 123 60,414 64,933
85,402 67,871 (2,795) (621) 76,720 159,760
426,645 403,834 (2,293) (209) 124,220 80,054
23,461 18,720 22,540 17,805 378 393
403,184 385,114 (24,833) (18,014) 123,842 79,661
94,152 65,849 (8,204) (5,950) 13,039 30,194
309,032 319,265 (16,629) (12,064) 110,803 49,467
8,155 13,372 578 678
300,877 305,893 (16,629) (12,064) 110,225 48,789

Consolidated cash flow statement as at 31 March 2021

in EUR thousand 1.1.–31.3.2021 1.1.–31.3.2020
I.
Cash flow from operating activities
Net income 319,265 309,032
Appreciation/depreciation 36,684 31,843
Net realised gains and losses on investments (90,182) (101,864)
Change in fair value of financial instruments (through profit or loss) 49,699 (11,644)
Amortisation of investments 32,887 2,940
Changes in funds withheld (217,412) (369,606)
Net changes in contract deposits 146,125 (73,665)
Changes in prepaid reinsurance premium (net) 1,453,513 1,260,744
Changes in tax assets /provisions for taxes 115,470 (507)
Changes in benefit reserve (net) (36,915) (61,328)
Changes in claims reserves (net) 1,038,231 805,250
Changes in deferred acquisition costs (309,184) (229,746)
Changes in other technical provisions 42,118 20,811
Changes in clearing balances (1,011,773) (552,145)
Changes in other assets and liabilities (net) 117,751 (95,190)
Cash flow from operating activities 1,686,277 934,925
II. Cash flow from investing activities (2,288,056) (563,518)
III. Cash flow from financing activities 689,173 (47,883)
IV. Exchange rate differences on cash 48,900 (25,211)
Cash and cash equivalents at the beginning of the period 1,278,071 1,090,852
Change in cash and cash equivalents (I. + II. + III. + IV.) 136,294 298,313
Cash and cash equivalents at the end of the period 1,414,365 1,389,165
thereof cash and cash equivalents of the disposal group 9,221
Cash and cash equivalents at the end of the period excluding the disposal group 1,414,365 1,379,944
Supplementary information on the cash flow statement 1
Income taxes paid (on balance) 56,209 (63,172)
Dividend receipts 2 60,828 27,439
Interest received 360,910 388,693
Interest paid (92,920) (51,613)

1 The income taxes paid, dividend receipts as well as interest received and paid are included entirely in the cash flow from operating activities.

2 Including dividend-like profit participations from investment funds

Other information

The present document is a quarterly statement pursuant to Section 51a of the Exchange Rules for the Frankfurter Wertpapierbörse (BörsO FWB). It was drawn up according to International Financial Reporting Standards (IFRS) as applicable in the EU, but does not constitute an interim financial report as defined by IAS 34 "Interim Financial Reporting" or a financial statement as defined by IAS 1 "Presentation of Financial Statements". Estimates are subject to a greater degree of uncertainty in view of the coronavirus pandemic.

The accounting policies are essentially the same as those applied in the consolidated financial statement as at 31 December 2020. In the 2021 financial year, the following amendments to standards

  • Amendments to IFRS 9, IAS 39 and IFRS 17: Interest Rate Benchmark Reform – Phase 2
  • Amendments to IFRS 4 Insurance Contracts deferral of IFRS 9, Extension of the Temporary Exemption from Applying IFRS 9

were to be applied for the first time. Hannover Re is exercising the temporary exemption from applying IFRS 9 "Financial Instruments" that is available to companies whose activities are predominantly connected with insurance.

Contact information

Corporate Communications

Karl Steinle Tel. + 49 511 5604-1500 Fax + 49 511 5604-1648 [email protected]

Media Relations

Oliver Süß Tel. + 49 511 5604-1502 Fax + 49 511 5604-1648 [email protected]

Investor Relations

Axel Bock Tel. + 49 511 5604-1736 Fax + 49 511 5604-1648 [email protected]

Published by

Hannover Rück SE Karl-Wiechert-Allee 50 30625 Hannover, Germany Tel. +49 511 5604-0 Fax +49 511 5604-1188

www.hannover-re.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.